Kaplan-Meier survival analysis among patients treated nonintensive blast-reduction strategies. (A) Comparison of OS among patients achieving CR/CRi, cMPN, or SD as best response. (B) Comparison of OS by ELN 2022 response criteria; CR/CRi vs NR/R. (C) Comparison of OS among patients with cMPN reclassified to either responders or nonresponders by ELN 2022 criteria.